Clinical Trial

Effect of Rectal Administration of Breast Milk on Gut Microbiota in Preterm Infants

Study acronym: premic
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the effect of rectal administration of maternal breast milk on gut microbiota development in preterm infants. Preterm infants are at increased risk of dysbiosis due to immaturity and limited enteral feeding in the early postnatal period. In this randomized controlled study, preterm infants will receive either rectal administration of maternal breast milk or normal saline. The primary objective is to compare gut microbiota composition between the two groups. The findings may provide insight into a novel and non-invasive strategy to support microbiota development in preterm infants.
Trial Details
NCT Number NCT07558499
Lead Sponsor Zekai Tahir Burak Women's Health Research and Education Hospital
Collaborators: Umraniye Education and Research Hospital, Kocaeli University
Conditions Premature, Gut Microbiota Diversity and Composition, NEC - Necrotizing Enterocolitis
Enrollment 60 participants
Start Date 2026-06-15
Primary Completion 2027-06-15 (estimated)
Study Completion 2027-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-30